Wille P R, Vitor R, Gabilan N H, Nicolau M
Departamento de Ciencias Fisiologicas, Universidade Federal de Santa Catarina, Florianopolis, Brazil.
Mediators Inflamm. 2001 Jun;10(3):163-7. doi: 10.1080/09629350124164.
The present study was performed to: (a) evaluate the effects of kinin B1 (Sar[D-Phe8]-des-Arg9-BK; 10 nmol/kg) and B2 (bradykinin (BK); 10 nmol/kg) receptor agonists on plasma extravasation in selected rat tissues; (b) determine the contribution of a lipopolysaccharide (LPS) (100 microg/kg) to the effects triggered by B1 and B2 agonists; and (c) characterize the selectivity of B1 ([Leu8]desArg9-BK; 10 nmol/kg) and B2 (HOE 140; 10 nmol/kg) antagonists as inhibitors of this kinin-induced phenomenon. B1 and B2 agonists were shown to increase plasma extravasation in the duodenum, ileum and also in the urinary bladder of the rat. LPS pretreatment enhanced the plasma extravasation mediated only by the B1 agonist in the duodenum, ileum, trachea, main and segmentar bronchi. These effects were prevented by the B1. but not the B2 antagonist. In normal rats, the B2 antagonist inhibited the effect of B2 agonist in all the tissues analyzed. However, in LPS-treated rats, the B2 antagonist was ineffective in the urinary bladder. These results indicate that kinins induce plasma extravasation in selected rat tissues through activation of B1 and B2 receptors, and that LPS selectively enhances the kinin effect on the B1 receptor in the duodenum, ileum, trachea and main and segmentar bronchi, and may increase B1 receptor expression in these tissues.
(a) 评估激肽B1(Sar[D-苯丙氨酸8]-去-精氨酸9-缓激肽;10 nmol/kg)和B2(缓激肽(BK);10 nmol/kg)受体激动剂对特定大鼠组织中血浆外渗的影响;(b) 确定脂多糖(LPS)(100 μg/kg)对B1和B2激动剂引发的效应的作用;(c) 表征B1([亮氨酸8]去精氨酸9-缓激肽;10 nmol/kg)和B2(HOE 140;10 nmol/kg)拮抗剂作为这种激肽诱导现象抑制剂的选择性。结果表明,B1和B2激动剂可增加大鼠十二指肠、回肠以及膀胱中的血浆外渗。LPS预处理增强了仅由B1激动剂介导的十二指肠、回肠、气管、主支气管和段支气管中的血浆外渗。这些效应可被B1拮抗剂阻断,但不能被B2拮抗剂阻断。在正常大鼠中,B2拮抗剂可抑制B2激动剂在所有分析组织中的效应。然而,在LPS处理的大鼠中,B2拮抗剂在膀胱中无效。这些结果表明,激肽通过激活B1和B2受体诱导特定大鼠组织中的血浆外渗,并且LPS选择性增强了激肽对十二指肠、回肠、气管以及主支气管和段支气管中B1受体的作用,并可能增加这些组织中B1受体的表达。